DD235867A5 - Verfahren zur herstellung von 1,4-dihydropyridinen - Google Patents
Verfahren zur herstellung von 1,4-dihydropyridinen Download PDFInfo
- Publication number
- DD235867A5 DD235867A5 DD85276212A DD27621285A DD235867A5 DD 235867 A5 DD235867 A5 DD 235867A5 DD 85276212 A DD85276212 A DD 85276212A DD 27621285 A DD27621285 A DD 27621285A DD 235867 A5 DD235867 A5 DD 235867A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- sub
- methyl
- formula
- evaporated
- dichlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Dental Preparations (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848412208A GB8412208D0 (en) | 1984-05-12 | 1984-05-12 | Quinolone inotropic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD235867A5 true DD235867A5 (de) | 1986-05-21 |
Family
ID=10560892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85276212A DD235867A5 (de) | 1984-05-12 | 1985-05-10 | Verfahren zur herstellung von 1,4-dihydropyridinen |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4654353A (sv) |
| EP (1) | EP0161917B1 (sv) |
| JP (1) | JPS60246368A (sv) |
| KR (1) | KR880000131B1 (sv) |
| AT (1) | ATE50988T1 (sv) |
| AU (1) | AU554257B2 (sv) |
| CA (1) | CA1278573C (sv) |
| DD (1) | DD235867A5 (sv) |
| DE (1) | DE3576499D1 (sv) |
| DK (1) | DK162982C (sv) |
| ES (2) | ES8609252A1 (sv) |
| FI (1) | FI83308C (sv) |
| GB (1) | GB8412208D0 (sv) |
| GR (1) | GR851130B (sv) |
| HU (1) | HU194172B (sv) |
| IE (1) | IE57751B1 (sv) |
| IL (1) | IL75165A (sv) |
| NO (1) | NO851886L (sv) |
| NZ (1) | NZ212033A (sv) |
| PH (1) | PH20931A (sv) |
| PL (1) | PL253328A1 (sv) |
| PT (1) | PT80427B (sv) |
| SU (1) | SU1417795A3 (sv) |
| YU (1) | YU78085A (sv) |
| ZA (1) | ZA853543B (sv) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU199796B (en) * | 1985-08-06 | 1990-03-28 | Boehringer Biochemia Srl | Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds |
| GB8526411D0 (en) * | 1985-10-25 | 1985-11-27 | Pfizer Ltd | Dihydropyridines |
| GB8527698D0 (en) * | 1985-11-09 | 1985-12-11 | Pfizer Ltd | Dihydropyridine antiischaemic & antihypertensive agents |
| IT1213555B (it) * | 1986-12-11 | 1989-12-20 | Boehringer Biochemia Srl | 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono. |
| US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
| GB8709447D0 (en) * | 1987-04-21 | 1987-05-28 | Pfizer Ltd | Dihydropyridines |
| US6541479B1 (en) * | 1997-12-02 | 2003-04-01 | Massachusetts College Of Pharmacy | Calcium channel blockers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
| CA1117117A (en) * | 1978-10-10 | 1982-01-26 | Fujisawa Pharmaceutical Co., Ltd. | 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same |
| SE7910521L (sv) * | 1979-12-20 | 1981-06-21 | Haessle Ab | Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma |
| CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
| DE3363743D1 (en) * | 1982-07-22 | 1986-07-03 | Pfizer Ltd | Dihydropyridine anti-ischaemic and antihypertensive agents |
| DE3311005A1 (de) * | 1983-03-25 | 1984-09-27 | Bayer Ag, 5090 Leverkusen | Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| EP0164247B1 (en) * | 1984-06-07 | 1989-01-11 | Pfizer Limited | Dihydropyridines |
-
1984
- 1984-05-12 GB GB848412208A patent/GB8412208D0/en active Pending
-
1985
- 1985-04-26 US US06/727,704 patent/US4654353A/en not_active Expired - Lifetime
- 1985-05-07 PH PH32235A patent/PH20931A/en unknown
- 1985-05-09 GR GR851130A patent/GR851130B/el unknown
- 1985-05-09 JP JP60098876A patent/JPS60246368A/ja active Granted
- 1985-05-09 PT PT80427A patent/PT80427B/pt not_active IP Right Cessation
- 1985-05-10 PL PL25332885A patent/PL253328A1/xx unknown
- 1985-05-10 DK DK207885A patent/DK162982C/da active
- 1985-05-10 CA CA000481320A patent/CA1278573C/en not_active Expired - Fee Related
- 1985-05-10 IL IL75165A patent/IL75165A/xx unknown
- 1985-05-10 AU AU42269/85A patent/AU554257B2/en not_active Ceased
- 1985-05-10 IE IE1168/85A patent/IE57751B1/en not_active IP Right Cessation
- 1985-05-10 YU YU00780/85A patent/YU78085A/xx unknown
- 1985-05-10 FI FI851857A patent/FI83308C/sv not_active IP Right Cessation
- 1985-05-10 EP EP85303304A patent/EP0161917B1/en not_active Expired - Lifetime
- 1985-05-10 NO NO851886A patent/NO851886L/no unknown
- 1985-05-10 ZA ZA853543A patent/ZA853543B/xx unknown
- 1985-05-10 HU HU851778A patent/HU194172B/hu unknown
- 1985-05-10 AT AT85303304T patent/ATE50988T1/de not_active IP Right Cessation
- 1985-05-10 DE DE8585303304T patent/DE3576499D1/de not_active Expired - Fee Related
- 1985-05-10 DD DD85276212A patent/DD235867A5/de unknown
- 1985-05-10 NZ NZ212033A patent/NZ212033A/en unknown
- 1985-05-10 ES ES543033A patent/ES8609252A1/es not_active Expired
- 1985-05-11 KR KR1019850003214A patent/KR880000131B1/ko not_active IP Right Cessation
- 1985-05-11 SU SU853901005A patent/SU1417795A3/ru active
-
1986
- 1986-01-16 ES ES550965A patent/ES8703429A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0071819B1 (de) | Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung | |
| EP0002208B1 (de) | Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung | |
| EP0176956B1 (de) | Neue Diarylverbindungen | |
| DE2935451A1 (de) | Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel | |
| DE3207982A1 (de) | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln | |
| DE3234684A1 (de) | Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln | |
| CH633266A5 (en) | Process for preparing 1,4-dihydropyridine compounds | |
| EP0343193A1 (de) | 1,4-dihydropyridine-enantiomere | |
| CH642353A5 (de) | 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel. | |
| DE3445852A1 (de) | Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| EP0039863B1 (de) | 1,4-Dihydropyridine mit unterschiedlichen Substituenten in 2- und 6-Position, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DD235867A5 (de) | Verfahren zur herstellung von 1,4-dihydropyridinen | |
| US4861782A (en) | Certain 2h-benzo[a]quinolizin-2-yl-aminoalkyl esters of 1,4-dihydro-3,5-pyridinedicarboxylates useful for treating circulation disorders | |
| DE3601397A1 (de) | Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| EP0242829A1 (de) | Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP0362632A2 (de) | Basische 4-Aryl-DHP-amide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DE3816361A1 (de) | 1,4-dihydropyridindicarbonsaeure-(-)-menthylester | |
| EP0244595A2 (de) | Dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| KR100355973B1 (ko) | 페닐-치환1,4-디히드로피리딘 | |
| DE3789411T2 (de) | Dihydropyridin-5-phosphonsaure zyklische Ester. | |
| US4957930A (en) | Dihydropyridine derivatives | |
| EP0308608A1 (de) | Neue substituierte Nitro-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| WO1986003748A1 (en) | New piperazine derivatives | |
| WO1988007531A1 (en) | New optically active compounds | |
| AT368494B (de) | Verfahren zur herstellung von neuen nitrosubstituierten 1,4-dihydropyridinen |